Levidiotis V - Search Results

1

New approaches to the treatment of dense deposit disease.

Smith RJ, Alexander J, Barlow PN, Botto M, Cassavant TL, Cook HT, de Córdoba SR, Hageman GS, Jokiranta TS, Kimberling WJ, Lambris JD, Lanning LD, Levidiotis V, Licht C, Lutz HU, Meri S, Pickering MC, Quigg RJ, Rops AL, Salant DJ, Sethi S, Thurman JM, Tully HF, Tully SP, van der Vlag J, Walker PD, Würzner R, Zipfel PF; Dense Deposit Disease Focus Group. Smith RJ, et al. Among authors: levidiotis v. J Am Soc Nephrol. 2007 Sep;18(9):2447-56. doi: 10.1681/ASN.2007030356. Epub 2007 Aug 5. J Am Soc Nephrol. 2007. PMID: 17675665 Free PMC article. Review.

2

A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis.

Levidiotis V, Freeman C, Punler M, Martinello P, Creese B, Ferro V, van der Vlag J, Berden JH, Parish CR, Power DA. Levidiotis V, et al. J Am Soc Nephrol. 2004 Nov;15(11):2882-92. doi: 10.1097/01.ASN.0000142426.55612.6D. J Am Soc Nephrol. 2004. PMID: 15504941

3

Heparanase in glomerular diseases.

van den Hoven MJ, Rops AL, Vlodavsky I, Levidiotis V, Berden JH, van der Vlag J. van den Hoven MJ, et al. Among authors: levidiotis v. Kidney Int. 2007 Sep;72(5):543-8. doi: 10.1038/sj.ki.5002337. Epub 2007 May 23. Kidney Int. 2007. PMID: 17519955 Free article. Review.

4

Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis.

Levidiotis V, Freeman C, Tikellis C, Cooper ME, Power DA. Levidiotis V, et al. J Am Soc Nephrol. 2004 Jan;15(1):68-78. doi: 10.1097/01.asn.0000103229.25389.40. J Am Soc Nephrol. 2004. PMID: 14694159

5

Pregnancy and maternal outcomes among kidney transplant recipients.

Levidiotis V, Chang S, McDonald S. Levidiotis V, et al. J Am Soc Nephrol. 2009 Nov;20(11):2433-40. doi: 10.1681/ASN.2008121241. Epub 2009 Sep 24. J Am Soc Nephrol. 2009. PMID: 19797167 Free PMC article.

6

New insights into the molecular biology of the glomerular filtration barrier and associated disease.

Levidiotis V, Power DA. Levidiotis V, et al. Nephrology (Carlton). 2005 Apr;10(2):157-66. doi: 10.1111/j.1440-1797.2005.00385.x. Nephrology (Carlton). 2005. PMID: 15877676 Review.

7

Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease.

Levidiotis V, Freeman C, Tikellis C, Cooper ME, Power DA. Levidiotis V, et al. Nephrology (Carlton). 2005 Apr;10(2):167-73. doi: 10.1111/j.1440-1797.2005.00388.x. Nephrology (Carlton). 2005. PMID: 15877677

8

A study of VEGF and its receptors in two rat models of proteinuria.

Kanellis J, Levidiotis V, Khong T, Cox AJ, Stacker SA, Gilbert RE, Cooper ME, Power DA. Kanellis J, et al. Among authors: levidiotis v. Nephron Physiol. 2004;96(1):P26-36. doi: 10.1159/000075577. Nephron Physiol. 2004. PMID: 14752241

9

Predictors of early dialysis vascular-access failure after thrombolysis.

Crikis S, Lee D, Brooks M, Power DA, Ierino FL, Levidiotis V. Crikis S, et al. Among authors: levidiotis v. Am J Nephrol. 2008;28(2):181-9. doi: 10.1159/000110086. Epub 2007 Oct 24. Am J Nephrol. 2008. PMID: 17960056

10

Corticosteroids worsen proteinuria and increase intraglomerular signaling by NF-ĸB in a model of membranous glomerulonephritis.

Mudge SJ, Paizis K, Auwardt RB, Levidiotis V, Fraser SA, Power DA. Mudge SJ, et al. Among authors: levidiotis v. Nephron Exp Nephrol. 2010;116(2):e23-31. doi: 10.1159/000317128. Epub 2010 Jun 29. Nephron Exp Nephrol. 2010. PMID: 20588061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters